| Nancy A Schaefer, MD | |
|
100 Ter Heun Drive, Falmouth Hospital, Falmouth, MA 02540 | |
| (508) 457-3929 | |
| (508) 457-3839 |
| Full Name | Nancy A Schaefer |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 29 Years |
| Location | 100 Ter Heun Drive, Falmouth, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720054117 | NPI | - | NPPES |
| AA14021 | Other | MA | HPHC |
| J21385 | Other | MA | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 159886 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Falmouth Hospital | Falmouth, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urgi Center Medical Group | 3476790601 | 74 |
News Archive
CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, at the Meenakshi Mission Hospital and Research Centre in Madurai, Tamil Nadu, India, the first clinical site in India.
Expression of the Sry-related HMG box 2 gene is higher in small-celllung cancer tissue samples than in non-cancerous lung tissue samples, according to findings from a genetic study.
About 20 minutes into the debate come the questions about Mitt Romney's health care plan in Massachusetts, against which he defends his record and pivots to Obamacare. He says he would repeal it.
Protalix BioTherapeutics, Inc., announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application (NDA) for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.
A tool developed by researchers from UPM allows us to assess usability during the design and testing process of accessible ICT-based applications.
› Verified 8 days ago
| Entity Name | Falmouth Hospital Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336106806 PECOS PAC ID: 4385632942 Enrollment ID: O20040503001218 |
News Archive
CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, at the Meenakshi Mission Hospital and Research Centre in Madurai, Tamil Nadu, India, the first clinical site in India.
Expression of the Sry-related HMG box 2 gene is higher in small-celllung cancer tissue samples than in non-cancerous lung tissue samples, according to findings from a genetic study.
About 20 minutes into the debate come the questions about Mitt Romney's health care plan in Massachusetts, against which he defends his record and pivots to Obamacare. He says he would repeal it.
Protalix BioTherapeutics, Inc., announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application (NDA) for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.
A tool developed by researchers from UPM allows us to assess usability during the design and testing process of accessible ICT-based applications.
› Verified 8 days ago
| Entity Name | Medical Affiliates Of Cape Cod Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770534927 PECOS PAC ID: 3577471564 Enrollment ID: O20040510001010 |
News Archive
CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, at the Meenakshi Mission Hospital and Research Centre in Madurai, Tamil Nadu, India, the first clinical site in India.
Expression of the Sry-related HMG box 2 gene is higher in small-celllung cancer tissue samples than in non-cancerous lung tissue samples, according to findings from a genetic study.
About 20 minutes into the debate come the questions about Mitt Romney's health care plan in Massachusetts, against which he defends his record and pivots to Obamacare. He says he would repeal it.
Protalix BioTherapeutics, Inc., announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application (NDA) for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.
A tool developed by researchers from UPM allows us to assess usability during the design and testing process of accessible ICT-based applications.
› Verified 8 days ago
| Entity Name | Emergency Physicians Of Falmouth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376828988 PECOS PAC ID: 9032377569 Enrollment ID: O20120229000783 |
News Archive
CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, at the Meenakshi Mission Hospital and Research Centre in Madurai, Tamil Nadu, India, the first clinical site in India.
Expression of the Sry-related HMG box 2 gene is higher in small-celllung cancer tissue samples than in non-cancerous lung tissue samples, according to findings from a genetic study.
About 20 minutes into the debate come the questions about Mitt Romney's health care plan in Massachusetts, against which he defends his record and pivots to Obamacare. He says he would repeal it.
Protalix BioTherapeutics, Inc., announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application (NDA) for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.
A tool developed by researchers from UPM allows us to assess usability during the design and testing process of accessible ICT-based applications.
› Verified 8 days ago
| Entity Name | Urgi Center Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902146798 PECOS PAC ID: 3476790601 Enrollment ID: O20130508000075 |
News Archive
CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, at the Meenakshi Mission Hospital and Research Centre in Madurai, Tamil Nadu, India, the first clinical site in India.
Expression of the Sry-related HMG box 2 gene is higher in small-celllung cancer tissue samples than in non-cancerous lung tissue samples, according to findings from a genetic study.
About 20 minutes into the debate come the questions about Mitt Romney's health care plan in Massachusetts, against which he defends his record and pivots to Obamacare. He says he would repeal it.
Protalix BioTherapeutics, Inc., announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application (NDA) for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.
A tool developed by researchers from UPM allows us to assess usability during the design and testing process of accessible ICT-based applications.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nancy A Schaefer, MD 100 Ter Heun Drive, Falmouth Hospital, Falmouth, MA 02540 Ph: (508) 457-3929 | Nancy A Schaefer, MD 100 Ter Heun Drive, Falmouth Hospital, Falmouth, MA 02540 Ph: (508) 457-3929 |
News Archive
CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, at the Meenakshi Mission Hospital and Research Centre in Madurai, Tamil Nadu, India, the first clinical site in India.
Expression of the Sry-related HMG box 2 gene is higher in small-celllung cancer tissue samples than in non-cancerous lung tissue samples, according to findings from a genetic study.
About 20 minutes into the debate come the questions about Mitt Romney's health care plan in Massachusetts, against which he defends his record and pivots to Obamacare. He says he would repeal it.
Protalix BioTherapeutics, Inc., announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application (NDA) for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.
A tool developed by researchers from UPM allows us to assess usability during the design and testing process of accessible ICT-based applications.
› Verified 8 days ago
Herbert E Gray Iii, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Ter Haun Drive, Falmouth, MA 02540 Phone: 508-457-3929 Fax: 508-457-3839 | |
Mark K Durfee, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Ter Heun Drive, Falmouth Hospital Emergency Department, Falmouth, MA 02540 Phone: 508-457-3929 Fax: 508-457-3839 | |
Dr. Justin C Popso, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Ter Heun Dr, Falmouth, MA 02540 Phone: 508-457-3929 | |
Mark F Losordo, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Ter Haun Drive, Falmouth, MA 02540 Phone: 508-457-3929 Fax: 508-457-3839 | |
Jonathan R Pilcher, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Ter Heun Dr, Falmouth Hospital - Emergency Department, Falmouth, MA 02540 Phone: 508-457-3929 Fax: 508-457-3839 | |
Thomas A Hanna, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Ter Haun Drive, Falmouth, MA 02540 Phone: 508-457-3929 Fax: 508-457-3839 | |
Diane M. Daddario, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Ter Heun Dr, Emergency Department, Falmouth, MA 02540 Phone: 508-457-3929 Fax: 508-457-3839 |